
Embody closed a $10.4 million Series C funding round led by Genesis Innovation Group’s cultivate(MD) Capital Funds. The financing will enable Embody to expand operations and postmarket clinical studies of the recently launched Tapestry RC System for rotator cuff repair, as well as prepare for launch of ActivBraid™ high-strength collagen-based suture technology in 2023.
“This financing represents a notable step in the continued growth of Embody,” said Jeff Conroy, Embody’s Founder and Chief Executive Officer. “We are thrilled to have the continued support of our highly seasoned investor base, further illustrating the opportunity and need of our soft tissue healing technology portfolio.”
Embody has developed a next-generation regenerative platform with novel collagen-based bio-fabrication techniques and products for the fast-growing sports medicine market, including rotator cuff repair, foot & ankle and knee.
Sources: Embody; cultivate(MD)
Embody closed a $10.4 million Series C funding round led by Genesis Innovation Group's cultivate(MD) Capital Funds. The financing will enable Embody to expand operations and postmarket clinical studies of the recently launched Tapestry RC System for rotator cuff repair, as well as prepare for launch of ActivBraid™ high-strength collagen-based...
Embody closed a $10.4 million Series C funding round led by Genesis Innovation Group’s cultivate(MD) Capital Funds. The financing will enable Embody to expand operations and postmarket clinical studies of the recently launched Tapestry RC System for rotator cuff repair, as well as prepare for launch of ActivBraid™ high-strength collagen-based suture technology in 2023.
“This financing represents a notable step in the continued growth of Embody,” said Jeff Conroy, Embody’s Founder and Chief Executive Officer. “We are thrilled to have the continued support of our highly seasoned investor base, further illustrating the opportunity and need of our soft tissue healing technology portfolio.”
Embody has developed a next-generation regenerative platform with novel collagen-based bio-fabrication techniques and products for the fast-growing sports medicine market, including rotator cuff repair, foot & ankle and knee.
Sources: Embody; cultivate(MD)
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





